Fingerprint
Dive into the research topics of 'Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically